Team_Arcana

Team Arcana

Team Arcana

Add article description

Team Arcana is a Japanese video game developer and a successor of Examu, which mostly produce fighting games for arcades and home consoles. It is known for developing the Arcana Heart series, the company's namesake, as well as Daemon Bride series. Team Arcana's existence as a re-branded successor of Examu had been dated back to Arcana Heart series' crossover inclusion in BlazBlue: Cross Tag Battle.

Quick Facts Native name, Company type ...

At the end of February 2020, its predecessor, Examu suspended its business operations. Any ongoing development works and product supports (most particularly ongoing supported fighting games (including licensed fighting games)) have migrated to Team Arcana.[2]

Games

See also: Examu § Games
More information Game, Release Date ...

References

  1. [1]
    "高屋校長とチームアルカナ-新作格ゲー開発室- - DMM". DMM.com.
  2. [2]
    "株式会社エクサム" [Examu Ltd. – Company] (in Japanese). Retrieved September 5, 2015.
  3. [3]
    Romano, Sal (November 20, 2018). "Million Arthur: Arcana Blood for PS4 currently only planned for Japanese release". Gematsu. Retrieved December 8, 2018.
  4. [4]
    O'Connor, Alice (February 19, 2019). "Million Arthur: Arcana Blood punching to PC this summer". Rock Paper Shotgun. Gamer Network Ltd. Retrieved March 26, 2019.
  5. [5]
    Stenbuck, Kite (April 30, 2021). "Arcana Heart 3 Xtend DLC Characters Are Now Available to the Public". Siliconera. Retrieved May 1, 2021.
  6. [6]
    "The ultimate version of ARCANA HEART 3 comes to exA-Arcadia in ARCANA HEART 3 XTEND by Team ARCANA". exA-Arcadia. exA-Arcadia. February 10, 2023. Retrieved February 10, 2023.
  7. [7]
    "JAEPO 2023にてTeam ARCANA × exA-Arcadia 第2弾『デモンブライドexAGAIN』を電撃発表！". exA-Arcadia. exA-Arcadia. February 10, 2023. Retrieved February 10, 2023.
Stub icon

This Japanese video game corporation or company article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Team_Arcana, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.